Drug intelligence / Profile preview

VanaLice

Development stage
Unknown
Lead developer
GM Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

VanaLice is an over-the-counter (OTC) topical gel developed and marketed by GM Pharmaceuticals for the treatment of lice infestations (pediculosis), including head lice, pubic (crab) lice, and body lice. The product is a combination of two active pediculicides: **pyrethrins** (derived from pyrethrum extract) and **piperonyl butoxide**. Pyrethrins function as neurotoxins that disrupt the nervous system of lice by prolonging the opening of voltage-gated sodium channels, leading to paralysis and death. Piperonyl butoxide acts as a synergist by inhibiting the cytochrome P450 enzymes in the lice that would otherwise metabolize and detoxify the pyrethrins. The formulation also incorporates essential oils such as tea tree, coconut, and lemongrass oil. It is indicated for use in adults and children aged 2 years and older and is typically supplied as a kit including a fine-tooth nit removal comb.

Brand names
VanaLiceVanaLice Lice Killing Gel Kit
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on VanaLice.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VanaLice.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call